ClearCount Medical Solutions Inc. raised $1.1 million in the first tranche of a Series B funding round it hopes will total $5 million.
The funding was detailed in a regulatory filing and confirmed by CFO Dave Haffner.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
ClearCount Medical Solutions Inc. raised $1.1 million in the first tranche of a Series B funding round it hopes will total $5 million.
The funding was detailed in a regulatory filing and confirmed by CFO Dave Haffner.
Results from Abbott’s (NYSE:ABT) Spirit IV trial, which the company said confirms the superiority of its Xience V drug-eluting stent over Boston Scientific Corp.’s (NYSE:BSX) Taxus, were published today in the New England Journal of Medicine.
Medtronic Inc. (NYSE:MDT) launched a clinical trial of a neurostimulator designed for patients suffering from chronic pain.
The RestoreSensor neurostimulator is unique because it uses a proprietary sensor that enables it to adjust the amount of electricity being delivered to a patient, based on the patient’s body position, according to a press release.
Athenahealth Inc. (NSDQ:ATHN) paid dearly for its efforts to increase its market penetration during the first quarter, which saw profits plunge despite health top-line growth.
The Watertown, Mass.-based electronic medical records provider posted sales of $54.5 million during the three months ended March 31, up 32.8 percent compared with $41.0 million during the same period last year.
But net income plunged 82 percent to $277,000, or 1 cent per share, compared with $1.5 million, or 4 cents per share, during Q1 2009.
By Mary Vanac
STERIS Corp. (NYSE: STE) continued its quest to make operations more efficient in fiscal 2010, leading to higher profits for the year. However, like so many other companies dealing with market uncertainties, revenues fell.
Medtronic Inc. (NYSE:MDT) is notifying health authorities that some of its cardiac devices may contain a software bug.
The Minneapolis, Minn.-based medical device monolith said there are software problems in six models of its implantable defibrillators, according to the reported7thSpace website. The company says the issue may be life-threatening, but the malfunction is rare and no injuries or deaths have resulted from the product defect, according to the website.
MassDevice.com is blogging on the topic of building innovative medical technology for the developing world, featuring some of the leading minds in the field.
This feature will continue up through May 17th and the first annual World Health Medical Technology Conference at Boston University.
Cambridge Heart Inc. (OTC:CAMH) issued a call for nearly $1 million worth of long-term warrants it issued last year as part of a Series D funding round.
The Tewksbury, Mass.-based heart test maker said it would net $754,000 if all holders of the warrants for 6,775,611 shares exercise them at their 14.2 cent share price. Cambridge Heart already pulled in $208,000 from the exercise of some of the warrants.
If your medical devices are exported to Europe, are they being sold in Italy? If so, have they been registered with the Italian Ministry of Health’s online "repertorio" database? If not, starting May 5, they will no longer be able to be sold to National Health Service facilities, nor be entered for public purchasing tenders.
One of the frustrating aspects of the European Medical Devices Directives is that member states are allowed discretion on certain requirements, including registration of higher-risk devices. Italy initially went beyond the directives’ requirements and required registration of Class I devices in addition to those in higher-risk classes.
A federal judge in Michigan tossed a whistleblower lawsuit against Stryker Corp. (NYSE:SYK) that accused the company of a kickbacks scheme, but gave the plaintiffs a window to amend their complaint.
Judge Robert Jonker of the U.S. District Court for Western Michigan ruled that Robert Laucirica and the U.S. government failed to prove their contention that Stryker sales reps initiated a kickbacks scheme with Dr. Hari Parvataneni, an orthopedic surgeon at the University of Miami’s Jackson Memorial Hospital.
Stoughton, Mass.-based STD Med Inc. won $43,000 in workforce development funding from Massachusetts.
The grant is part of $1.3 million in workforce training funds for Bay State.-based companies announced by Gov. Deval Patrick April 27.